ngagement of integrin receptors with the extracellular matrix induces the formation of focal adhesions (FAs). Dynamic regulation of FAs is necessary for cells to polarize and migrate. Key interactions between FA scaffolding and signaling proteins are dependent on tyrosine phosphorylation. However, the precise role of tyrosine phosphorylation in FA development and maturation is poorly defined. Here, we show that phosphorylation of type I ␥ phosphatidylinositol phosphate kinase (PIPKI ␥ 661) on tyrosine 644 (Y644) is critical for its interaction with E talin, and consequently, localization to FAs. PIPKI ␥ 661 is specifically phosphorylated on Y644 by Src. Phosphorylation is regulated by focal adhesion kinase, which enhances the association between PIPKI ␥ 661 and Src. The phosphorylation of Y644 results in an ‫ف‬ 15-fold increase in binding affinity to the talin head domain and blocks ␤ -integrin binding to talin. This defines a novel phosphotyrosine-binding site on the talin F3 domain and a "molecular switch" for talin binding between PIPKI ␥ 661 and ␤ -integrin that may regulate dynamic FA turnover.
Introduction
Integrin binding to the ECM stimulates the formation of cell-matrix adhesions and mediates the linkage between the ECM and actin cytoskeleton (for review see Zamir and Geiger, 2001 ). This linkage is generated by a submembrane interconnecting complex that consists of structural proteins such as talin, vinculin, paxillin, ␣ -actinin, and tensin, signaling molecules including tyrosine kinases such as FAK and Src, and serine/threonine kinases, as well as various adaptor proteins. The molecular complexity of cell-matrix adhesions enables them to modulate both cell anchorage and transmembrane signaling (Sastry and Burridge, 2000; . The most common forms of integrin-mediated cell-matrix adhesions in cultured cells are termed focal adhesions (FAs), fibrillar adhesions, or focal complexes, based on their size, shape, and location within the cell. Signal transduction through FAs has been implicated in the regulation of a number of key cellular processes, including growth factor-induced mitogenic signals, cell survival, cell locomotion and morphogenesis, and tissue assembly (Burridge and Chrzanowska-Wodnicka, 1996) .
The dynamic regulation of FA assembly and disassembly is the central process for cell motility in response to extracellular stimuli (for review see Parsons et al., 2000) . In addition to regulation by Rho family small GTPases, another key mechanism for modulation of FA organization and stability is tyrosine phosphorylation. Nonreceptor tyrosine kinases, FAK, and Src family kinases are involved in the phosphorylation of several FA proteins including paxillin, p130Cas, tensin, and FAK itself (for review see Cary and Guan, 1999; Frame et al., 2002) . Tyrosine phosphorylation provides docking sites for additional molecules that contain phosphotyrosine (pY)-binding (PTB) domains (for review see Zamir and Geiger, 2001 ). Inhibition of tyrosine kinases decreases the level of intracellular tyrosine phosphorylation and blocks the development of FAs (for review see Frame et al., 2002) . Consistently, activation of protein tyrosine phosphatases disrupts FAs, whereas their inhibition stimulates FA assembly. On the other hand, overactivated Src results in high levels of tyrosine phosphorylation but disruption of FAs (Kellie et al., 1986) , and Src Ϫ / Ϫ cells form FAs that fail to turn over into fibrillar adhesions (Volberg et al., 2001 ). In addition, Src family kinases were implicated in regulation of integrincytoskeleton interactions (Felsenfeld et al., 1999) . These data suggest that tyrosine phosphorylation plays an essential role in the formation and turnover of FAs. However, the exact mechanism underlying tyrosine phosphorylation-mediated modification of the integrin-cytoskeleton linkage and FA dynamics are still poorly defined.
Phosphatidylinositol 4,5-bisphosphate (PI4,5P 2 ), a lipid second messenger, modulates FA formation by binding to vinculin, ␣ -actinin, and talin facilitating protein-protein interactions and by regulating Rho family small G proteins (for review see Sechi and Wehland, 2000) . The concentration of PI4,5P 2 appears to be regulated locally, enabling spatial and temporal changes in its availability and signaling. Type I ␥ 661 phosphatidylinositol phosphate kinase (PIPKI ␥ 661) targets to FAs and regulates FA assembly by generating PI4,5P 2 and targeting talin to FAs (Di Paolo et al., 2002; Ling et al., 2002) . Our previous data showed that PIPKI ␥ 661 was tyrosine phosphorylated by FAK signaling, and this enhances PIP kinase activity and correlated with increased talin association . Here, we demonstrate that PIPKI ␥ 661 is tyrosine phosphorylated on Y644 by Src family kinases and is potentially regulated by FAK signaling. Tyrosine phosphorylation of PIPKI ␥ 661 is required for its strong talin interaction and stable FA targeting. Interestingly, PIPKI ␥ 661 tyrosine phosphorylation strengthens its interaction with talin, effectively competing with ␤ 1-integrin for binding to talin. The combined data support a novel mechanism regulating FA dynamics by tyrosine phosphorylation and PI4,5P 2 signaling.
Results
FAK signaling mediates the tyrosine phosphorylation of PIPKI ␥ 661 at Y644 Previously, we observed that tyrosine phosphorylation of PIPKI ␥ 661 was dependent on adhesion and FAK signaling . Here, we show that PIPKI ␥ 661 tyrosine phosphorylation is dependent on both FAK phosphorylation on Y397 and FAK activity because neither coexpressed Y397F nor kinase-dead mutants of FAK induced phosphorylation of PIPKI ␥ 661 (Fig. 1 A) . To map the phosphorylation sites, we used the following PIPKI ␣ / ␥ chimeras: PIPKI ␣ / ␥ 635, PIPKI ␣ / ␥ 661, and PIPKI ␣ / ␥ 636-661 as defined in the Materials and methods. We coexpressed the chimeras with wild-type FAK, and then analyzed their tyrosine phosphorylation by immunoprecipitation and immunoblotting. Both PIPKI ␣ / ␥ 661 and PIPKI ␣ / ␥ 636-661 (but not PIPKI ␣ / ␥ 635) were phosphorylated after FAK coexpression (Fig. 1 B) . The COOH-terminal truncation mutants of PIPKI ␥ 661 showed consistent results; PIPKI ␥ 661 ⌬ 20 (1-641) was not phosphorylated, PIPKI ␥ 661 ⌬ 13 (1-648) was phosphorylated but to a lesser extent, and PIPKI ␥ 661 ⌬ 3 (1-657) was phosphorylated similar to the wild-type kinase (unpublished data). These data suggest that the major FAKmediated phosphorylation sites are in the last 26 amino acids of PIPKI ␥ 661. To define the phosphorylated residues, two Y to F point mutants were made, Y644F and Y649F (Fig. 1  C) . The wild-type or Y to F mutant PIPKI ␥ 661 was coexpressed in HEK293T cells with wild-type FAK or vector control, and tyrosine phosphorylation of PIPKI ␥ 661 was determined after immunoprecipitation using anti-PIPKI ␥ antibody. As shown in Fig. 1 C, when FAK was overexpressed, PIPKI ␥ 661Y649F was phosphorylated similar to the wild type. However, PIPKI ␥ 661Y644F and PIPKI ␥ 661Y644/ 649F showed dramatically reduced phosphorylation (Fig. 1  C) , suggesting that Y644 is the phosphorylation site downstream of FAK signaling. (I␣/I␥636-661) , and wild-type HA-tagged PIPKI␥661 (I␥661) were cotransfected with pcDNA3 (1) or wild-type FAK (2) in HEK293 cells for 48 h. Tyrosine phosphorylation of the PIPKI constructs was examined by immunoprecipitation and Western blot as indicated. (C) The wild-type (I␥661) and Y to F mutant (I␥661Y644F, I␥661Y649F, I␥661Y644/649F) PIPKI␥661 constructs were co-overexpressed in HEK293T cells with pcDNA3 (1) or wild-type FAK (2) for 48 h, and tyrosine phosphorylation of the PIPKI␥661 constructs was examined using immunoprecipitation and Western blot as indicated.
c-Src directly phosphorylates PIPKI ␥ 661 at Y644
Src family tyrosine kinases are key factors that associate with FAK, thereby playing a fundamental role in downstream signaling and FAK-regulated processes (Parsons et al., 2000) . Y397 is the autophosphorylation site in FAK and serves as a Src-binding site. Previous results have shown that either the Src-binding site (Y397) mutant or a kinase-dead mutant abrogated FAK's ability to promote PIPKI ␥ 661 phosphorylation (Fig. 1 A) . This suggests that phosphorylation of PIPKI ␥ 661 is mediated by Src or FAK. To address the role of Src family kinases in PIPKI ␥ 661 phosphorylation, Src activity was examined. The Src-specific inhibitor PP2 (but not the inactive analogue PP3) inhibited both basal and FAK-induced tyrosine phosphorylation of PIPKI ␥ 661 (Fig. 2 A) , showing that Src family kinases play an important role in tyrosine phosphorylation of PIPKI ␥ 661. To further explore this possibility, we used the c-Src, Fyn, and Yes triple knockout cells (SFY Ϫ / Ϫ ) and c-Src-reintroduced SFY Ϫ / Ϫ cells (Src ϩ / ϩ ) to analyze the tyrosine phosphorylation of endogenous PIPKI ␥661. As shown in Fig. 2 B, endogenous PIPKI␥661 showed very low phosphorylation in SFY Ϫ/Ϫ cells, whereas reintroduced c-Src restored PIPKI␥661 phosphorylation. Our results indicate that c-Src is directly involved in the tyrosine phosphorylation of PIPKI␥661, whereas the role of other Src family kinases members Fyn and Yes need further clarification. When the FAK knockout (FAK Ϫ/Ϫ ) or their parent (FAK ϩ/ϩ ) cells were examined, the endogenous PIPKI␥661 showed similar tyrosine phosphorylation in both cell lines (Fig. 2 B) , indicating that FAK did not phosphorylate PIPKI␥661 directly, but enhanced its phosphorylation via regulation of Src.
These whole-cell assays were confirmed by in vitro kinase assays, which demonstrated that c-Src directly phosphorylated the His-tagged recombinant PIPKI␥661 tail (439-661; Fig. 2 C) , whereas FAK only phosphorylated it very weakly (unpublished data). Both His-tagged recombinant PIPKI␥661Y644F and PIPKI␥661Y644/649F tails were not efficiently phosphorylated by c-Src in vitro compared with the wild-type PIPKI␥661, whereas the PIPKI␥Y649F tail was efficiently phosphorylated (Fig. 2 C) . Furthermore, the phosphopeptide-mapping results confirmed that Y644 is the major substrate of c-Src because the Y644F mutant failed to yield two major phosphorylation spots compared with the wild-type PIPKI␥661 map (Fig. 2 D) . These results demonstrate that Y644 is the major tyrosine phosphorylation site of PIPKI␥661 and that Src is the enzyme responsible for PIPKI␥661 phosphorylation.
c-Src associates with PIPKI␥661, and this is enhanced by FAK To decipher the mechanism of PIPKI␥661 phosphorylation by Src, we examined whether there was an interaction between Src and PIPKI␥661. HEK293T cells were cotransfected with c-Src and PIPKI␥661 for 48 h, harvested, and PIPKI␥661 was immunoprecipitated with purified anti-PIPKI␥ antibody. As shown in Fig. 3 A, c-Src was coimmunoprecipitated with PIPKI␥661. To further explore FAK's role in PIPKI␥661 phosphorylation, we coexpressed FAK with c-Src and PIPKI␥661. Coexpression of the wild-type FAK enhanced both tyrosine phosphorylation and Src association with PIPKI␥661 (Fig. 3 B) . FAKY397F, which lacks the docking site for Src, inhibited the PIPKI␥661-c-Src association and failed to increase PIPKI␥661 phosphorylation to ) cells were used for immunoprecipitation using purified anti-PIPKI␥ antibody. Then, tyrosine phosphorylation of immunoprecipitated PIPKI␥ was analyzed by Western blot as indicated. (C) In vitro Src kinase assay with His-tagged wild-type (wt-T) or mutant (Y644F-T, Y649F-T, or Y644/649F-T) PIPKI␥661 tails as substrates. Phosphorylation data were analyzed using SigmaPlot 4.0 from at least three independent experiments. (D) Analysis of tyrosine phosphorylation by tryptic phosphopeptide mapping. In vitro Src kinase assays using the substrates described in C were resolved by SDS-PAGE, and the tryptic digests of the tyrosine-phosphorylated substrates were analyzed on two-dimensional maps (exposure for 7 d at Ϫ70ЊC). Arrows indicate the spots corresponding to the loss of phosphorylation in the Y644F mutant. The large horizontal arrow points to the cathode and the large vertical arrow indicates the direction of chromatographic resolution.
the same extant as FAK (Fig. 3 B) . This demonstrates that the interaction of Src with FAK is required for FAK signaling to enhance Src binding and phosphorylation of PIPKI␥661.
Nevertheless, the PIPKI␥661 phosphorylation by Src is not absolutely dependent on FAK because PIPKI␥661 can be phosphorylated in FAK-null cells (Fig. 2 B) . In addition, PIPKI␥635 and the PIPKI␥661 Y to F mutants coimmunoprecipitated with c-Src (unpublished data), suggesting that c-Src association with PIPKI␥ requires a site distinct from the last 26 amino acids of PIPKI␥661 and independent of phosphorylation at Y644 or Y649. In A431 cells, endogenous PIPKI␥661 was tyrosine phosphorylated and associated with endogenous Src upon cell adhesion to type I collagen (Fig. 3  C) . These results indicate that signals initiated from integrin binding to ligand regulate the Src-PIPKI␥661 association, and consequently, tyrosine phosphorylation of PIPKI␥661. The requirement of integrin-mediated cell adhesion suggests that FAK regulation is one potential signaling pathway that modulates the Src-PIPKI␥ interaction. A431 cells highly express EGF receptors and, as a result, Src activity could be greatly enhanced. In other cell lines assayed, including HEK293T, NRK, and NIH3T3, the interaction between endogenous PIPKI␥661 and Src was more difficult to detect, although endogenous PIPKI␥661 is tyrosine phosphorylated in these cell lines and is dependent on adhesion on type I collagen (unpublished data; Ling et al., 2002) .
Tyrosine phosphorylation regulates the PIPKI␥661-talin association and FA targeting of PIPKI␥661
Tyrosine phosphorylation of FA proteins regulates cell spreading and migration by generating protein-protein interaction sites for SH2 and PTB domains (for review see Immunoprecipitates were analyzed by Western blot as indicated. (C) A431 cells were lifted by trypsin, washed three times, and kept in suspension for 1 h at 37ЊC in serum-free DME. Cells were lysed (sus.) or plated on type I collagen-coated (10 g/ml) plates in serum-free DME for the indicated time and then lysed, immunoprecipitated, and analyzed by Western blot as indicated. Data were quantified using NIH image 1.62 and plotted using SigmaPlot 4.0 from at least three independent experiments. Panetti, 2002) . To further explore the physiological significance of PIPKI␥661 tyrosine phosphorylation, we determined if the endogenous PIPKI␥661 bound to talin is tyrosine phosphorylated. Compared with endogenous PIPKI␥661 immunoprecipitated by anti-PIPKI␥ antibody, endogenous PIPKI␥661 coimmunoprecipitated by antitalin antibody had equivalent tyrosine phosphorylation but less PIPKI␥661 (Fig. 4 A) , suggesting that PIPKI␥661 bound to talin is tyrosine phosphorylated to a greater extent than free PIPKI␥661 in vivo.
Cotransfection experiments also indicated that increased PIPKI␥661 tyrosine phosphorylation, induced by FAK, correlates with an increase in PIPKI␥661 bound to talin (Fig. 4  B ; Ling et al., 2002) . To characterize the role of PIPKI␥661 tyrosine phosphorylation, we examined the talin interaction with PIPKI␥661 phosphorylation-defective mutants by coimmunoprecipitation using HEK293T cells. Compared with the wild-type PIPKI␥661, PIPKI␥661⌬20 did not interact with talin, PIPKI␥661⌬13 had decreased talin association, and PIPKI␥661⌬3 maintained identical talin association (Fig. 4 C) . The tyrosine point mutants PIPKI␥661Y644F and PIPKI␥661Y644/649F both showed substantially diminished talin association, whereas PIPKI␥Y649F retained talin association comparable with wild-type PIPKI␥661 (Fig. 4 C) . These data demonstrate that tyrosine phosphorylation of the PIPKI␥661 COOH terminus regulates its interaction with talin.
The PIPKI␥661-talin association is important for targeting PIPKI␥661 to FAs (Di Paolo et al., 2002; Ling et al., 2002) . To further explore targeting requirements, FA localization of PIPKI␥661 mutants were examined in NRK cells. Consistent with the ability to interact with talin in coimmunoprecipitation experiments, PIPKI␥661⌬20 lost FA targeting, PIPKI␥661⌬3 targeted to FAs and colocalized with talin similar to wild-type PIPKI␥661, and PIPKI␥661⌬13 partially retained FA targeting (Fig. 5 A) . These data indicate that in addition to the minimum region 642 WVYSPLH 648 for in vitro talin binding (Di Paolo et al., 2002) , in vivo talin association, FA targeting, and phosphorylation of PIPKI␥661 also require other residues in the COOH-terminal 26 amino acids. Consistently, the Y to F mutants lacking phosphorylation showed reduced talin association (Fig. 4 C) and lost FA targeting, whereas PIPKI␥Y649F localized to FAs similar to its wild-type counterpart (Fig. 5 A) . Analysis of 600 cells under each condition in three independent experiments revealed a correlation with talin association (Fig. 4 C) , FA targeting (Fig. 5 B) , and tyrosine phosphorylation of PIPKI␥661 (Fig. 1 B) . Addition- ally, PIPKI␥661 overexpressed in Src ϩ/ϩ cells showed significantly greater FA targeting and colocalization with the pY staining compared with those overexpressed in SFY Ϫ/Ϫ cells (Fig. 5 C) . In the FAK Ϫ/Ϫ cells, overexpressed PIPKI␥661 showed comparable FA targeting as in the parent cells (unpublished data), consistent with results demonstrating that FAK does not directly phosphorylate PIPKI␥661 in vivo. Together, these data show that c-Src-induced tyrosine phosphorylation of PIPKI␥661 enhances its FA targeting.
Tyrosine phosphorylation of PIPKI␥661 enhances talin interaction
To determine whether phenylalanine substitution or loss of the phosphorylated tyrosine is responsible for the reduced talin binding of PIPKI␥661 mutants, talin interactions were assessed by GST pull-down using recombinant nonphosphorylated His-PIPKI␥661 wild-type or Y to F mutant COOH terminus and GST-talin head domain. His-PIPKI␥661 Y to F mutants showed identical binding to talin compared with the wild-type protein (Fig. 6 A) , suggesting that the decreased in vivo talin association resulted from the lack of tyrosine phosphorylation and not the phenylalanine substitution.
To address the role of tyrosine phosphorylation, we designed PIPKI␥661 peptides containing the talin-binding sequence 642 WVYSPLH 648 and flanking sequences, including normal peptide (PN), Y644-phosphorylated (pY644), Y649-phosphorylated (pY649), or Y644/Y649 dual-phosphorylated (pY644/649) peptides (Fig. 6 B) . HEK293T cell lysates were supplemented with these peptides and subsequently used for immunoprecipitation. The phosphorylated peptides inhibited PIPKI␥661-talin association much more efficiently than the nonphosphorylated peptide (Fig. 6 B) . To further explore this, we labeled the PIPKI␥661 peptides with fluorescein at the NH 2 terminus and examined their direct binding with purified GST-talin head using fluorescence polarization anisotropy. As shown in Fig. 6 C, all of the phosphorylated peptides showed higher binding affinity for GST-talin head compared with the nonphosphorylated peptide. These results demonstrate that PIPKI␥661 tyrosine phosphorylation enhances talin binding.
Phosphorylated PIPKI␥661 competes with ␤1-integrin for talin binding
Talin plays a key role in integrin-mediated signaling by linking integrins to the actin cytoskeleton and regulating integrin activation . The F3 lobe of the band 4.1, ezrin, radixin, moesin homology (FERM) domain of talin, structurally homologous to a PTB domain, binds to the ␤-integrin cytoplasmic tail (Calderwood et al., 2002; Garcia-Alvarez et al., 2003) and the last 26 amino acids of PIPKI␥661 (Di Paolo et al., 2002; . Because tyrosine phosphorylation of PIPKI␥661 enhanced its interaction with talin, it is important to explore whether PIPKI␥661 would displace ␤-integrin from talin in a phosphorylation-dependent manner. We examined the ability of recombinant PIPKI␥ proteins or peptides to compete with His-␤1-integrin tail for binding to talin in vitro. His-PIPKI␥661 tail, but not His-PIPKI␥635 tail, competed with His-␤1-integrin tail in a dose-dependent manner (Fig.  7 A) , consistent with the recent report by Barsukov et al. 2003) . In addition, we found that the phosphorylated PIPKI␥661 peptides were ‫-02ف‬fold more effective in displacement of His-␤1-integrin tail from GST-talin head than the nonphosphorylated peptide (Fig. 7 B) . The analysis of the integrin competition data revealed that Y644 or Y649 single-or double-phosphorylated PIPKI␥661 peptides shared similar efficiencies for displacing His-␤1-integrin tail from GST-talin head that is ‫-02ف‬fold higher than the nonphosphorylated PIPKI␥661 peptide (Fig. 7 C) . Our current data suggest that tyrosine-phosphorylated PIPKI␥661 could be a key element in Src-mediated regulation of integrincytoskeleton linkage by competing with ␤-integrin binding to the talin FERM domain. PIPKI␥661 binds to talin on an overlapping yet distinct site from ␤-integrin, and K357 and R358 of talin are responsible for the enhanced binding of phosphorylated PIPKI␥661 As a key residue for binding to talin (Di Paolo et al., 2002) , W642 of PIPKI␥661 aligns with the conserved tryptophan in the ␤-integrin tail (Garcia-Alvarez et al., 2003) . PIPKI␥661 binding to talin through an interaction with W642 would position Y644 of PIPKI␥661 adjacent to K357 and R358 of talin. To determine if the increased binding affinity of the phosphorylated PIPKI␥661 sequences was due to these two basic residues, each residue was respectively mutated to glutamine, which is the most conservative mutation that eliminates charge but maintains side chain size. Although both K357Q and R358Q mutants abolished His-␤1-integrin tail binding, neither mutation had a detectable effect on His-PIPKI␥661 tail binding (Fig. 8 A) . The binding curves of His-PIPKI␥661 tail to the wild-type or mutant GST-talin head showed comparable properties (Fig. 8 B) , showing that both K357Q and R358Q mutants have no effect on talin binding to PIPKI␥661. These data indicate that PIPKI␥661 binds to talin on an overlapping yet distinct site compared with ␤1-integrin, as concluded by Barsukov et al. (2003) .
To assess the impact of PIPKI␥661 phosphorylation, the phosphorylated peptides were used to compete with His-PIPKI␥661 binding to the wild-type or mutant GST-talin head. As shown in Fig. 8 C, the K357Q mutant retained high affinity binding for the Y644-phosphorylated peptide, but lower affinity for the Y649-phosphorylated peptide. R358Q showed a loss of increased affinity for both Y644-and Y649-phosphorylated peptides (Fig. 8 C) . These results indicate that both phosphorylated Y644 and Y649 require R358 for high affinity binding, but phosphorylated Y649 appeared to also require K357. To further examine this hypothesis, we examined the direct binding of fluoresceinlabeled PIPKI␥661 peptides with the mutant GST-talin head. To the K357Q mutated talin head, the binding affinity of Y649-phosphorylated peptide dropped to the comparable level with the nonphosphorylated peptide, whereas the Y644-and double-phosphorylated peptides maintained their higher binding affinity (Fig. 8 D) . All of the phosphorylated peptides showed decreased binding affinity to the R358Q mutant compared with the wild-type talin head (Fig. 8 D) , suggesting that R358 is critical for phosphorylated PIPKI␥661 peptide binding. The anisotropy data revealed that phosphorylation at Y644 or Y649 enhanced the binding affinity to talin head ‫-51ف‬fold. These results support the GST pull-down displacement data that K357 is responsible for tighter binding induced by phosphorylation of Y649, whereas R358 is critical for tighter binding to talin induced by phosphorylation of both Y644 and Y649. Both nonphosphorylated and phosphorylated PIPKI␥661 peptides showed 3-4 times lower maximum change of anisotropy with the R358Q talin head mutant, consistent with the recent work by Barsukov et al. (2003) . Previous data demonstrate that there is no detectable effect on full-length PIPKI␥661 tail binding to R358Q talin head (Fig. 8, A and  B) . This gives rise to the possibility that residues in the last 26 amino acids other than the 15 amino acids in the synthesized PIPKI␥661 peptide are involved in the interaction The interactions between 100 nM GST-TaH and 100 nM His-␤1InT, with indicated amounts of synthesized PIPKI␥661 peptides, were examined by GST pull-down assay and analyzed by Western blot as indicated. (C) The displacement curves of synthesized PIPKI␥661 peptides binding to GST-TaH in competition with His-␤1InT were obtained by GST pull-down and Western blot. Both talin head bands and integrin tail bands were quantified by NIH image 1.62, and data were plotted by SigmaPlot 4.0 from at least three independent experiments.
with talin head domain. In addition, the K d value of nonphosphorylated PIPKI␥661 peptide for the full talin head is eightfold lower than the reported value for F2F3 domain of talin (Barsukov et al., 2003) , suggesting additional contribution to the binding energy.
Because dimerization of GST may introduce artifactual results, we also performed experiments using His-tagged PIPKI␥661 tail and S-tagged recombinant talin head proteins to repeat the representative results. These experiment showed consistent results with those obtained from the GST pull-downs (unpublished data).
Tyrosine phosphorylation of ␤1-integrin tail decreases its interaction with talin
The enhanced association of the phosphorylated PIPKI␥661 peptides with talin raised the question of whether the ␤1-integrin tail may bind to talin with increased affinity when phosphorylated at the 780 WDT 782 and 785 NPIY 788 motif because the WDT motif aligns with 642 WVY 644 of PIPKI␥661. To address this question, ␤1-integrin peptides phosphorylated at T783 and/or Y788 were synthesized and used to compete integrin tail binding to talin. The T783-phosphorylated peptide competed with the integrin tail for talin to a similar extent as the nonphosphorylated peptide, whereas the Y788-phosphorylated peptide showed lower binding affinity (Fig. 9) . These data indicate that phosphorylation of the Y788 residue diminished the interaction with GST-talin, consistent with previous reports (Tapley et al., 1989; GarciaAlvarez et al., 2003) . These results identify a region on the F3 lobe of talin as a PTB domain that can bind both phosphorylated PIPKI␥661 or unphosphorylated integrin. The loss of talin binding to phosphorylated integrin and the enhanced binding to phosphorylated PIPKI␥661 defines a mechanism by which tyrosine phosphorylation of PIPKI␥661 tightly regulates FA dynamics via an integrin-talin switch.
Discussion
PIPKI␥661 is a newly recognized FA-targeting phosphatidylinositol phosphate kinase isoform, and was identified as an important regulator for FA assembly through recruiting talin to and generating PI4,5P 2 at FAs (Di Paolo et al., 2002; Ling et al., 2002) . Previously, the tyrosine phosphorylation of PIPKI␥661 was shown to regulate its PIP kinase activity . The present work demonstrates that the PIPKI␥661-talin interaction and the PIPKI␥661 FA targeting require Src-mediated tyrosine phosphorylation of PIPKI␥661 at Y644. This enables PIPKI␥661 to produce PI4,5P 2 at FAs, thereby regulating FA assembly. Tyrosine phosphorylation has been shown to regulate FA turnover; however, the underlying mechanism is poorly defined. We speculate that tyrosine phosphorylation of PIPKI␥661 provides a plausible mechanism for the dynamic regulation of FA organization. PIPKI␥661 binds talin via the talin FERM domain. The binding region has been narrowed to the F3 lobe of the FERM domain, and this lobe has structural homology to PTB domains (Calderwood et al., 2002; Garcia-Alvarez et al., 2003) . Here, we have shown that phosphorylated PIPKI␥661 peptides bind with high affinity to the F3 lobe, and K357 and R358 are key residues that bestow increased affinity to tyrosine-phosphorylated PIPKI␥661. To understand the interaction between talin and phosphorylated PIPKI␥661, we structurally modeled the talin F3 lobe with the dual phosphorylated PIPKI␥661 peptide (Fig. 10 A) . This model shows that Y644 is located close to K357 and R358 of talin and forms a charge-charge interaction with these residues when phosphorylated. This model is supported by the observation that mutation of K357 and R358 to glutamine ablated the enhanced binding of the Y644-phosphorylated sequences. Unlike the integrin sequence, P646 of PIPKI␥661 creates a turn that also positions Y649 directly adjacent to K357 of talin. This model is consistent with the result that the K357Q mutant lost the enhanced binding to the Y649-phosphorylated PIPKI␥661 peptide. Y649 of PIPKI␥661 is in a similar position to Y788 of ␤1A-integrin, which was reported to be phosphorylated in Src-transformed cells (Sakai et al., 2001) . However, phosphorylation of Y788 resulted in the loss of integrin binding to the talin head ( Fig.  9 ; Tapley et al., 1989; Garcia-Alvarez et al., 2003) . This indicates that P786 of integrin locates integrin Y788 to a position where the tyrosine-phosphorylated residue may be sterically hindered from interacting with K357 or R358 of talin.
Our data demonstrate that the FERM domain of talin acts as a PTB domain by coordinating binding of two different tyrosine-phosphorylated sequences in PIPKI␥661. This may be a general function of FERM domains because the K357 and R358 positions are conserved in other FERM domains including moesin, radixin, ezrin, band 4.1. This suggests that there is structurally conserved binding between FERM domains and phosphorylated tyrosine residues in sequences similar to the PIPKI␥661 tail. In addition, the F3 lobe of talin does bind tyrosine-phosphorylated residues in the context of Y649 in the sequence PLHY, which is similar to the NPXY sequences that PTB domains normally bind. This demonstrates that the F3 lobe of talin is a remarkably flexible PTB domain that can bind two distinct phosphorylated tyrosine residues in different sequence contexts.
Current results suggest a mechanism as illustrated in Fig.  10 B, where talin switches between an association with integrin or PIPKI␥661 in a dynamic and highly regulated fashion. It is demonstrated here that both FAK and Src are involved in PIPKI␥661 tyrosine phosphorylation. Endogenous PIPKI␥661 tyrosine phosphorylation was dependent on adhesion to type I collagen, an ␣ 2 ␤ 1 integrin-dependent signaling process. As a component of this pathway, FAK activates Src, which then phosphorylates PIPKI␥661. In addition, FAK stimulates an association between Src and PIPKI␥661. This association was also stimulated by adhesion to type I collagen, indicating that the Src association is physiologically relevant. The Src-PIPKI␥661 association is likely important for efficient phosphorylation of PIPKI␥661. These combined data suggest that ␣ 2 ␤ 1 integrin signaling is one mechanism that leads to phosphorylation of PIPKI␥661.
The PIPKI␥661-binding site on talin overlaps with the integrin-binding site, and this competitive interaction is likely the key for modulation of PIPKI␥661 function at FAs. Current results demonstrate that tyrosine phosphorylation of PIPKI␥661 dramatically enhances talin interaction and FA targeting, which enable the generation of PI4,5P 2 at FAs to improve the integrin-talin interaction. The enhancement of the integrin-talin association by PI4,5P 2 may ultimately displace PIPKI␥661 from talin, resulting in a reduction of PI4,5P 2 . Via this mechanism, PI4,5P 2 production is self limiting, and in the context of this model would be highly dynamic. The tyrosine phosphorylation of PIPKI␥661 may also be regulated by PI4,5P 2 production because the kinase-dead enzyme is 20-fold less tyrosine phosphorylated . This results in a spatial and temporal generation of PI4,5P 2 that is regulated by integrin binding to ECM, and by Src, FAK, or other signals. Al- Figure 9 . Phosphorylation of ␤1-integrin tail does not increase interaction with talin. Top, sequences and nomenclature of the synthesized ␤1-integrin peptides. Bottom, the interactions between 100 nM GST-TaH and 100 nM His-␤1InT with indicated amount of indicated ␤1-integrin peptides. Structure model was generated with the Sybyl molecular modeling program using the crystal structure as guide to dock the phosphorylated peptides, which were then energy minimized with the talin F3 lobe. (B) Signaling mechanism depicting PIPKI␥661 regulation of FAs and the interplay with ␤-integrin.
though we have not yet identified a kinase that phosphorylates Y649, this potential phosphorylation site may be a link to other signaling pathways for the modulation of PIPKI␥661-talin association and FA dynamics.
FAK and Src family members are important regulators of FA dynamics (for review see Cary and Guan, 1999; Frame et al., 2002) . Src is required in directed migration stimulated by growth factors. There is also evidence that adhesion to the ECM is required for cells to become responsive to growth factors, and this responsiveness correlates with stimulation of PI4,5P 2 production by ECM adhesion (McNamee et al., 1993) . As shown in Fig. 10 B, Src activation by integrin leads to phosphorylation of PIPKI␥661, enhancing both talin binding and PIP kinase activity . Because growth factor receptor and integrin signaling regulate Src activity, both pathways may lead to phosphorylation of PIPKI␥661 and regulation of migration.
Recent work has revealed that talin provides the initial connections between the ECM, integrin, and the cytoskeleton (Jiang et al., 2003) . Moreover, talin binding to integrin has been identified as the final step leading to integrin activation (Tadokoro et al., 2003) . This "inside-out" integrin signaling modulates both integrin-binding affinity to the ECM and internal connection to the cytoskeleton via the regulated association with talin Calderwood et al., 1999 Calderwood et al., , 2002 Ulmer et al., 2003) . Currently, the only known enhancer of the integrin-talin interaction is PI4,5P 2 , which induces an ‫-01ف‬fold increase of the binding affinity (Martel et al., 2001) . Regulated production of PI4,5P 2 at FAs, via Src-mediated phosphorylation of PIPKI␥661, may be key for modulation of the integrin-talin interaction, and subsequently, integrin activity and binding affinity for the ECM. This would provide a mechanism by which migrating cells can spatially and temporally control adhesion to the ECM differently at the leading or trailing edge.
Materials and methods

Constructs
Human talin1 head region (1-435) was cloned from HEK293T cells by RT-PCR using the OneStep RT-PCR kit (QIAGEN) and was subcloned into pET42. The COOH-terminal truncated or site-directed mutagenesis for the PIPKI␥661 mutants or talin head was performed using PCR-primer overlap extension with mutagenic primers. PIPKI␥661 mutants were then subcloned into pcDNA3.1, and talin head mutants were subcloned into pET42. His-tagged mouse ␤1-integrin tail was made following the published method (Pfaff et al., 1998) , and was subcloned into pET28. The COOH terminus of PIPKI␥635 (439-635), PIPKI␥661 (439-661), or the Y to F mutants of PIPKI␥661 were PCR amplified from the corresponding pcDNA3.1 constructs and subcloned into pET28. PIPKI␣/␥439-635 or PIP-KI␣/␥439-661 were constructed by fusing residues 1-444 of PIPKI␣ and residues 439-635 of PIPKI␥635 (PIPKI␣/␥635) or 439-661 of PIPKI␥661 (PIPKI␣/␥661) as described in Ling et al. (2002) . PIPKI␣/␥636-661 was constructed by fusion of the COOH-terminal 26 residues of PIPKI␥661 (PIPKI␣/␥636-661) to the COOH terminus of PIPKI␣ as described by Ling et al. (2002) . All mutants were confirmed by DNA sequence analysis. FAK, FAKY397F, and kinase-dead FAK constructs were gifts from Dr. Patricia J. Keely (University of Wisconsin, Madison, Madison, WI). The c-Src construct was provided by Dr. Alan C. Rapraeger (University of Wisconsin, Madison, Madison, WI).
Cell cultures and transfection
HEK293T cells, NRK cells, and A431 cells were cultured using DME supplemented with 10% FBS. FAK Ϫ/Ϫ , FAK ϩ/ϩ , SFY Ϫ/Ϫ , and Src ϩ/ϩ cells, provided by Dr. Patricia J. Keely, were maintained in DME supplemented with 10% FBS. NRK cells were plated on glass coverslips and transfected using FuGENE™ 6 following the manufacturer's instructions. 0.5 ϫ 10 6 HEK293T cells were transfected by calcium phosphate using 2 g PIPKI␥ expression vectors together with 4 g empty pcDNA3 vector, 2 g empty pcDNA3 vector plus 2 g wild-type or mutant FAK, 2 g empty pcDNA3 vector plus 2 g c-Src, or 2 g wild-type or mutant FAK plus 2 g c-Src. SFY Ϫ/Ϫ and Src ϩ/ϩ cells were plated on glass coverslips for 16 h and then used for immunofluorescence.
blocked by 3% BSA in PBS at RT for 30 min, incubated with the primary antibody for 1 h at 37ЊC, washed with 0.1% Triton X-100 in PBS, incubated with fluorescence-labeled secondary antibody at RT for 30 min, and then washed with 0.1% Triton X-100 in PBS. Cells were maintained and examined using a 60ϫ Plan oil immersion lens on a confocal laser-scanning microscope (model MR-1000; Bio-Rad Laboratories) mounted transversely to an inverted microscope (Diaphot 200, Nikon; W.M. Keck Laboratory for Biological Imaging, Madison, WI). Images were processed as described previously using Photoshop ® 7.0.
